Clinical Trial Update: Combination Chemotherapy With or Without High Dose Cyclophosphamide and Recombinant Interferon Alfa-2b in Treating Patients With Previously Untreated Stage I-III Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating whether adding high-dose cyclophosphamide to chemotherapy with recombinant interferon alfa-2b benefits patients with previously …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Cytoxan (cyclophosphamide)
• Intron A (interferon alfa-2b)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Stage I Multiple Myeloma, Stage II Multiple Myeloma | Phase 3 | Status: COMPLETED